Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Directly Observed Preventive Therapy (DOPT) for Latent Tuberculosis Infection Patients With Poorly Controlled Diabetes Mellitus

NCT06874725 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.

NCT NCT06874725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06874725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Directly Observed Preventive Therapy (DOPT) for Latent Tuberculosis Infection Patients With Poorly Controlled Diabetes Mellitus
Lead sponsor
Taichung Veterans General Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 18, 2018
Completion date
April 18, 2025
Enrollment
552 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis infection